Login / Signup

Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.

Patrick HarringtonKatie J DooresJamie SaundersMarc de LordChandan SahaThomas LechmereHataf KhanHo Pui Jeff LamAmy O' ReillyClaire WoodleySusan AsirvathamRichard DillonNatalia Curto-GarciaJennifer O' SullivanShahram KordastiKavita RajMichael H MalimDeepti RadiaDonal P McLornanClaire HarrisonHugues de Lavallade
Published in: Blood cancer journal (2022)
Keyphrases
  • sars cov
  • immune response
  • respiratory syndrome coronavirus
  • low grade